CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Back to Top

Advertisement

Advertisement

EUROPEAN Company Directory


Concept Medical

5600 Mariner St., Suite 200 , Tampa, FL 33609

PHONE: (813) 210-9486

down-arrow Created with Sketch.
down-arrow Created with Sketch.

Balloons / PTCA Balloons

View Chart
Company Name Product Name Nominal Pressure (atm) Rated Burst Pressure (atm) Guidewire Compatibility (inch) Shaft Length (cm) Sheath Compatibility (F) Balloon Diameters (mm) Balloon Lengths (mm) Comments
Concept Medical MagicTouch SCB 6 bar 16 bar 0.014 maximum recommended 140 6 1.50, 2, 2.25, 2.50, 2.75, 3, 3.50, 4 10, 15, 20, 25, 30, 35, 40 Magic Touch is a sirolimus drug-coated balloon catheter for treatment of the coronary arteries; intended for treating in-stent restenosis, small vessel, bifurcations lesions, and de novo lesions

Advertisement

Advertisement

Balloons / Specialty Balloons

View Chart
Company Name Product Name Nominal Pressure (atm) Rated Burst Pressure (atm) Guidewire Compatibility (inch) Size (F) Sheath Compatibility (F) Shaft Length (cm) Balloon Diameters (mm) Balloon Lengths (cm)
Concept Medical MagicTouch ED 8 bar 14 bar 0.014 6 – – 1.50, 2, 2.25, 2.50, 2.75, 3, 3.50, 4 1, 1.5, 2, 2.5, 3, 3.5, 4

Balloons / Drug-Coated Balloons

View Chart
Company Name Product Name Drug Type Drug Concentration (µg/mm2) Excipient Type Guidewire Compatibility (inch) Shaft Length (cm) Sheath Compatibility (F) Balloon Diameters (mm) Balloon Lengths (cm)
Concept Medical MagicTouch AVF Sirolimus 1.27 Phospholipid 0.035 OTW 45, 90 6–8 3, 4, 5, 6, 7, 8, 9, 10, 12 2, 4, 6, 8, 10, 12, 15, 20
Concept Medical MagicTouch ED Sirolimus 1.27 Phospholipid 0.014 maximum recommended 140 6 1.5, 2, 2.25, 2.5, 2.75, 3, 3.5, 4 1, 1.5, 2, 2.5, 3, 3.5, 4
Concept Medical MagicTouch PTA 0.014 Sirolimus 1.27 Phospholipid 0.014 OTW 90, 120, 150 5–8 2, 2.5, 3, 3.5, 4 4, 6, 8, 10, 12, 15, 20
Concept Medical MagicTouch PTA 0.018 Sirolimus 1.27 Phospholipid 0.018 OTW 90, 120, 150 5–8 2, 2.5, 3, 3.5, 4, 5, 5.5, 6, 7 4, 6, 8, 10, 12, 15, 20
Concept Medical MagicTouch PTA 0.035 Sirolimus 1.27 Phospholipid 0.035 OTW 130, 150 5–8 3, 4, 5, 6, 7, 8, 9, 10, 12 2, 4, 6, 8, 10, 12, 15, 20
Concept Medical MagicTouch SCB Sirolimus 1.27 Phospholipid 0.014 maximum recommended 140 6 1.5, 2, 2.25, 2.5, 2.75, 3, 3.5, 4 1, 1.5, 2, 2.5, 3, 3.5, 4

Stents / Coronary Balloon-Expandable Drug-Eluting Stents

View Chart
Company Name Product Name Drug Delivered Material Used Polymer Type Maximum Guidewire Size (inch) Introducer Size (F) Stent Diameter (mm) Stent Length (mm) Delivery System Length (cm) CE Mark Indications
Concept Medical Abluminus DES+ Sirolimus Cobalt chromium alloy L605 Customized biodegradable polymer matrix 0.014 5 2.25, 2.50, 2.75, 3, 3.50, 4, 4.50, 5 8, 12, 16, 20, 24, 28, 32, 36, 40,44, 48, 52 RX 140 Indicated for DM and AMI
Concept Medical Abluminus NP Sirolimus Cobalt chromium alloy L605 Polymer free 0.014 5 2.25, 2.50, 2.75, 3, 3.50, 4 8, 12, 16, 20, 24, 28, 32, 36, 40 140 Indicated for improving luminal diameter in patients, including those with bleeding risks or those who have to undergo DAPT interruption in the near future for any surgery and who have associated risks, such as diabetes mellitus, symptomatic coronary artery disease, stable angina, unstable angina, or documented silent ischemia due to atherosclerotic lesions in native coronary arteries with a reference vessel diameter 2.25 to 4 mm and lesion length of ≤ 36 mm

More Categories:

Balloons Catheters Sheaths Stents Structural Heart Valves Wires Other Devices View All

Advertisement

Latest News


April 21, 2026

TECTONIC IDE Trial of Abbott’s Coronary IVL Device Completes Enrollment 

April 21, 2026

Conavi’s IVUS-OCT System for Intravascular Imaging Cleared by FDA

April 20, 2026

KingstronBio Announces First Implant of ProStyle M Transcatheter Mitral Valve System in Confirmatory Study

Most Read Articles


Advances in Wiring and Balloon Technology for Complex PCI

With Raghav Gattani, MD, and Lindsey Cilia, MD, FACC, FSCAI

For Suspected Coronary Calcium Nodules, What Is Your Step-by-Step PCI Strategy?

With Shrilla Banerjee, MD, FRCP, FESC; Jimmy L. Kerrigan, MD, FSCAI, FACC; and Aditya S. Bharadwaj, MD, FACC, FSCAI

New PCI Directions

By Louis Verreault-Julien, MD

Back to Top
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button